NEW YORK (Reuters Health) – Surveillance of people at high hereditary risk for pancreatic ductal adenocarcinoma (PDAC) can lead to
Continue reading »
mypharmacynews.com
Home »
NEW YORK (Reuters Health) – Surveillance of people at high hereditary risk for pancreatic ductal adenocarcinoma (PDAC) can lead to
Continue reading »(HealthDay)—For patients with metastatic colorectal cancer who have resectable liver metastases, survival outcomes at five years do not differ significantly
Continue reading »New breakthrough in the treatment of breast cancer? The treatment of cancer often proves to be extremely difficult. Doctors developed
Continue reading »